Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Impact of Croscarmelose Sodium obtained from different suppliers in a tablet performance
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: BARROCAS, Pedro (Bial - Portela & Cª, S.A., R&D Department - Pharmaceutical development, Trofa, Portugal)
- Co-author(s): Pedro Barrocas: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
Teofilo Vasconcelos: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
Patrício Soares-da-Silva: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
Ricardo Lima: R&D Department, Bial - Portela & Cª, S.A., Trofa, Portugal
BackgroundsCroscarmelose sodium is a super-disintegrants used in the pharmaceutical industry for the formulation of capsules, tablets and granules.
AimsThe objective of the present work was to assess the impact of croscarmelose sodium obtained from different suppliers on the granules and tablet performance.
MethodsA preliminary analysis was.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019